<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03770169</url>
  </required_header>
  <id_info>
    <org_study_id>D-FR-52120-252</org_study_id>
    <nct_id>NCT03770169</nct_id>
  </id_info>
  <brief_title>Validation of Patient Reported Outcome Measures for Use in Vulvodynia</brief_title>
  <official_title>Validation of Patient Reported Outcome Measures for Use in Vulvodynia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ipsen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ipsen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of this project is to demonstrate content validity and usability of the
      modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function
      Index (mFSFI), and pain on intercourse Numeric Rating Scale (NRS) for adult patients with
      Vulvodynia
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 18, 2019</start_date>
  <completion_date type="Actual">September 19, 2019</completion_date>
  <primary_completion_date type="Actual">September 19, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of mVPAQ</measure>
    <time_frame>1 week</time_frame>
    <description>Cognitive debrief and usability through interviews and completion of an electronic diary</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Validation of mFSFI</measure>
    <time_frame>1 week</time_frame>
    <description>Cognitive debrief and usability through interviews and completion of an electronic diary</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Validation of Pain on Intercourse Numeric Rating Scale (NRS)</measure>
    <time_frame>1 week</time_frame>
    <description>Cognitive debrief and usability through interviews and completion of an electronic diary. Pain on Intercourse NRS that describes pain experienced during this sexual intercourse episode by number. The higher is the number the worse is pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vulvar pain NRS</measure>
    <time_frame>1 week</time_frame>
    <description>Assess understanding of the appropriateness of the vulvar pain NRS through interview and completion of an electronic diary</description>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Vulvodynia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects referred by clinicians
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fluent in understanding, speaking and reading US-English

          -  Have vulvodynia with pain for at least 6 months

        Exclusion Criteria:

          -  Clinically significant history of alcohol/drug abuse or dependence within the last 2
             years
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ipsen Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Ipsen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Diego Sexual Medicine</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Vulvovaginal Disorders</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omaha OB-GYN Associates, PC</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center for Vulvovaginal Disorders</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>November 29, 2018</study_first_submitted>
  <study_first_submitted_qc>December 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2018</study_first_posted>
  <last_update_submitted>October 25, 2019</last_update_submitted>
  <last_update_submitted_qc>October 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vulvodynia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

